glp-1 in pill form for weight loss With FDA approval of Wegovy pill, new era of oral drugs begins New GLP-1 pill helps patients

Erratum to "dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: a narrative review and discussion of research needs" [obesity pillars 11C (2024)100121]

Understanding what to expect during semaglutide withdrawal helps set realistic expectations and prevent panic about a second shedding episode

Some people also experiment with timing in an effort to make side effects more manageable

doi: 10.1159/000519503

Results from a 20-week phase 1b clinical trial showed that a once-weekly dose of 2.4 mg cagrilintide in combination with an equal dose of semaglutide, collectively termed cagrisema, achieved up to 17.1% weight reduction in the obese population

If you have both metabolic conditions (diabetes or obesity) and depression, integrated care addressing both aspects is ideal